hours, which means that within the first 4 days more than 90% of the radiation is delivered,
which is followed by implantation procedure.
Report includes chapters which deeply display the following deliverable about industry :
• Interventional Oncology Solutions Market Research Objective and Assumption
• Interventional Oncology Solutions Market Purview - Report Description, Executive Summary,
and Coherent Opportunity Map (COM)
• Interventional Oncology Solutions Market Dynamics, Regulations, and Trends Analysis -
Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Interventional Oncology Solutions Market, By Regions
• Interventional Oncology Solutions Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Interventional Oncology Solutions Market Manufacturers Profiles/Analysis including Company
Basic Information, Manufacturing Base and Its Competitors.
• Interventional Oncology Solutions Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Interventional Oncology Solutions Market Forecast including Production, Consumption, Import
and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Interventional Oncology Solutions Market Regional Analysis:-
North America is expected to hold dominant position in the global interventional oncology
solutions market over the forecast period. This is owing to increasing mergers & acquisition and
research collaboration between manufacturers and universities in the region to develop novel
products. For instance, in 2015, Boston Scientific enhanced its interventional oncology portfolio
by acquiring spherical embolic technologies, Embozene and Oncozene microspheres, which were
developed by Celo Nova Biosciences. These spheres are designed to prevent flow of blood to the
targeted tissue and also reduce growth of tumors. Moreover, in 2016, Philips collaborated with
Yale School of Medicine to bring new innovations in the field of interventional oncology. Liver